Global Cell Harvesting Market to Exceed USD 11.68 Billion by 2031,...

Global Cell Harvesting Market to Exceed USD 11.68 Billion by 2031, Fueled by Growth in Cell Therapy and Biomanufacturing

Posted 2025-07-04 07:38:16

[Boston, 4 July 2025] – Clearview Market Insights (CVMI) predicts that the global cell harvesting market will increase from USD 5.21 billion in 2024 to USD 11.68 billion by 2031, with a compound annual growth rate (CAGR) of 12.1%. The rising demand for advanced cell harvesting technologies is driven by the growth in regenerative medicine, CAR-T cell therapy, and biomanufacturing.

Cell harvesting is a crucial step in translating research into clinical applications. As demand for cell therapies and biologics increases, the importance of scalable, automated, and contamination-free harvesting solutions has never been more evident," said Dr. Rina Gupta, senior bioprocessing analyst at CVMI.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-cell-harvesting-market/

Key Market Highlights

2024 Market Size: USD 5.21 billion
2031 Forecast: USD 11.68 billion
CAGR: 12.1% (2024–2031)

Growth Catalysts

· CAR-T and T-Cell Therapy Expansion: Growing demand for efficient harvesting systems.

· Biomanufacturing Growth: Crucial for antibody, vaccine, and cell therapy production.

· Automation Surge: Movement towards closed, single-use harvesting solutions.

Segment Insights

Top product type: Automated harvesting systems hold a 55% market share.
Key end users: Biopharma companies and CDMOs drive demand.
Regional Leaders: North America has the largest share, followed by Europe and Asia-Pacific.

Competitive Overview (2024)

Thermo Fisher – 21%: Comprehensive CTS™ and Dynabeads™ platforms.
Danaher (Cytiva) – 18%: Leading in cell processing automation.
Merck – 14%: Excelling in GMP-compliant harvesting solutions.
Others – 47%: Combination of specialty providers and regional manufacturers.

Outlook to 2031

The next decade will witness a shift toward modular, AI-integrated, closed-system harvesting technologies, enabling decentralized manufacturing and faster clinical deployment of cell-based therapies. Emerging markets will experience significant growth due to investments in regenerative medicine infrastructure.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369